Genoway vs Poxel S.A.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Genoway is the larger company by market value: $36 M against $22 M for Poxel S.A., 1.6 times as much (market caps of Jul 30, 2023 for Genoway and Jan 5, 2024 for Poxel S.A.). Genoway's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet. Poxel S.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Genoway JEH.F | Poxel S.A. POXEL.PA |
|---|---|---|
| Profile | ||
| Country | 🇫🇷 France | 🇫🇷 France |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Revenue | — | $7 M |
| Net income | — | $-20 M |
| Profitability | ||
| Gross margin | — | 55.7% |
| Operating margin | — | -52.8% |
| Net margin | — | -275.9% |
| Growth | ||
| Revenue growth | — | 235.5% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jul 2023 | Market cap Jan 2024; ratios FY2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Genoway or Poxel S.A.?
Genoway is the larger company by market value: $36 M against $22 M for Poxel S.A., 1.6 times as much (market caps of Jul 30, 2023 for Genoway and Jan 5, 2024 for Poxel S.A.). Genoway's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet. Poxel S.A.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
More about Genoway
More about Poxel S.A.
Sources#
Every figure on this page comes from these, with the date shown next to it.